Table 5

Immunogenicity of Melan-A and influenza peptides. The numbers correspond to the number of patients with T-cell responses to Melan-A, influenza, or both. In total, 43 patients were evaluable for immune response.

Treatment Group Number of Responder Patients
Total Melan-A Influenza Both
All patients (n=43) 16 13 10 7
saline (n=6) 2 0 2 0
AS02B (n=12) 2 1 1 0
IFA (n=17) 12 12 7 7
AS02B or IFA + IL-2 (n=8) 0 0 0 0